Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 219Carboplatin 218Specimen Handling 198Cisplatin 188Magnetic Resonance Spectroscopy 168Radiotherapy 152Bevacizumab 142Gemcitabine 135Cyclophosphamide 133Drug Therapy 118Capecitabine 118Paclitaxel 112Oxaliplatin 110Biopsy 107venetoclax 102Nivolumab 101Rituximab 83tislelizumab 81durvalumab 81toripalimab 77Fluorouracil 73Etoposide 72Dexamethasone 70sintilimab 67Radiosurgery 67Docetaxel 67Pemetrexed 65atezolizumab 64Azacitidine 63Injections 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × fisetin × Clear all
NCT06113016 2025-07-08

PROFFi

Jonsson Comprehensive Cancer Center

Phase 2 Recruiting
164 enrolled
Breast

Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8

NCT05595499 2025-07-02

Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors

Jonsson Comprehensive Cancer Center

Phase 2 Recruiting
88 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡